Changping Laboratory
38
15
15
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 38 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (38)
Neuromodulation of Different Doses to Treat TRD Guided by pBFS Technique
Role: lead
Individualized Transcranial Magnetic Stimulation in Parkinsonian Disorders
Role: collaborator
pBFS Guided High-dose rTMS Therapy for Treatment-Resistant Depression
Role: lead
SCAN Targeted Epidural Modulation for Parkinson's Disease
Role: lead
PIN in Combination With Sintilimab in Previously Treated pMMR/MSS CRC With Hepatic Metastases
Role: collaborator
Allogeneic γδT Cells in Glioblastoma
Role: collaborator
PIN in Combination With Anti-PD1 in Previously Treated Primary Hepatocellular Carcinoma
Role: collaborator
PIN in Combination With Anti-PD1 in Previously Treated Solid Tumor
Role: collaborator
pBFS-guided iTBS Over the Left DLPFC for Chronic PSCI
Role: lead
pBFS-guided cTBS at Different Doses for Aphasia After Stroke
Role: lead
pBFS-guided Dual-target cTBS for Aphasia After Stroke
Role: lead
pBFS-guided cTBS Over the Inferior Frontal Gyrus for Aphasia After Ischemic Stroke
Role: lead
pBFS-guided Multi-target cTBS for Aphasia After Stroke
Role: lead
pBFS-guided cTBS Over the Superior Temporal Gyrus for Aphasia After Ischemic Stroke
Role: lead
pBFS Guided rTMS Over Cognitive Control Network for ASD
Role: lead
Individualized Functional Imaging-Guided Repetitive Transcranial Magnetic Stimulation (rTMS) for Treating Postural Gait Disorders in Patients with Amyotrophic Lateral Sclerosis (ALS): a Randomized, Crossover, Controlled, Double-Blind Clinical Study
Role: collaborator
fMRI-guided Transcranial Magnetic Stimulation Treatment for Parkinson's Disease
Role: lead
Individualized Precision rTMS for Language Recovery in Patients After Ischemic Stroke: a Multi-center RCT
Role: lead
A Study to Evaluate the Safety and Efficacy of ATHENA CAR-T in Subjects With Systemic Lupus Erythematosus
Role: collaborator
pBFS-guided rTMS Over DMPFC for Treatment-Resistant Depression
Role: lead